ENZ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ENZ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Enzo Biochem's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 was $0.256. Enzo Biochem's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.
As of today (2024-04-25), Enzo Biochem's share price is $1.045. Enzo Biochem's Median PS Value is $0.00. Therefore, Enzo Biochem's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Enzo Biochem's Median PS Value or its related term are showing as below:
During the past 13 years, the highest Price to Median PS Value of Enzo Biochem was 4.55. The lowest was 0.62. And the median was 1.06.
The historical data trend for Enzo Biochem's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enzo Biochem Annual Data | |||||||||||||||||||||
Trend | Jul14 | Jul15 | Jul16 | Jul17 | Jul18 | Jul19 | Jul20 | Jul21 | Jul22 | Jul23 | |||||||||||
Median PS Value | Get a 7-Day Free Trial | 3.12 | 2.70 | 3.95 | 1.10 | - |
Enzo Biochem Quarterly Data | ||||||||||||||||||||
Apr19 | Jul19 | Oct19 | Jan20 | Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | |
Median PS Value | Get a 7-Day Free Trial | -0.48 | -0.87 | - | - | - |
For the Diagnostics & Research subindustry, Enzo Biochem's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Enzo Biochem's Price-to-Median-PS-Value falls into.
Enzo Biochem's Median PS Value for today is calculated as
Median PS Value | = | Revenue per Share (TTM) | * | 10-Year Median PS Ratio |
= | 0.256 | * | 0 | |
= | 0.00 |
10-Year Median PS Ratio is 0.
Enzo Biochem's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.256.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enzo Biochem (NYSE:ENZ) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Enzo Biochem's Price to Median PS Value for today is calculated as
Price to Median PS Value | = | Share Price | / | Median PS Value |
= | 1.045 | / | 0.00 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Enzo Biochem's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Steven J Pully | director | 9800 RICHMOND AVE, SUITE 700, HOUSTON TX 77042 |
James G. Wolf | 10 percent owner | 105, FLYWAY DRIVE, KIAWAH ISLAND SC 29455 |
Hamid Erfanian | officer: Chief Executive Officer | 527 MADISON AVENUE, NEW YORK NY 10022 |
Patricia Eckert | officer: Interim CFO | C/O ENZO BIOCHEM, INC., 81 EXECUTIVE BLVD, SUITE 3, FARMINGDALE NY 11735 |
Kara Cannon | officer: Chief Operating Officer | 527 MADISON AVE, NEW YORK NY 10022 |
Bradley Louis Radoff | director | 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098 |
David Bench | officer: CHIEF FINANCIAL OFFICER | ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022 |
Harbert Discovery Fund, Lp | 10 percent owner | HARBERT DISCOVERY FUND GP, LLC, 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203 |
Ian B. Walters | director | ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022 |
Mary Tagliaferri | director | 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158 |
Clemens Peter J Iv | 10 percent owner | 2383 N. BERRY'S CHAPEL RD., FRANKLIN TN 37069 |
Rebecca J. Fischer | director | ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022 |
Fabian Blank | 10 percent owner, other: See Remarks | ROEMERSTRASSE 6, BAD BERTRICH 2M 56864 |
Harbert Management Corp | 10 percent owner | 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203 |
Harbert Discovery Co-investment Fund I Gp, Llc | 10 percent owner | 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203 |
From GuruFocus
By GlobeNewswire GlobeNewswire • 06-02-2022
By Marketwired • 09-06-2023
By PurpleRose PurpleRose • 08-11-2022
By Value_Insider Value_Insider • 10-20-2022
By PRNewswire PRNewswire • 05-03-2023
By GuruFocusNews GuruFocusNews • 06-12-2022
By GuruFocusNews GuruFocusNews • 07-06-2022
By GuruFocusNews GuruFocusNews • 07-02-2022
By PurpleRose PurpleRose • 08-03-2022
By GuruFocusNews GuruFocusNews • 03-28-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.